RAVI KAUSHIK: Robotics, AI, Medtech & Diagnostics Leader
Founder & CEO, Global Robotics, AI, MedTech & Diagnostics Leader, Global Vice President, Medical Devices & Digital Health Innovator, CEO~$120M P&L, Growth Architect, NPD, Product Strategy & Commercial Excellence|
Ravi Kaushik is Founder & CEO of an innovation spin-off robotic AI enabled medtech startup called ROPHAI. Ravi is a transformational MedTech, Robotics, Diagnostics and biopharma executive with more than 25 years of global leadership experience across the United States, Asia Pacific, and Europe,
His career spans CEO & VP level executive roles at reputed healthcare and life sciences organizations—including Takeda, Transasia Biomedicals, Medtronic, Baxter/Baxalta, and GE Healthcare—where he has led innovation, scaled businesses commercially, and delivered strong financial and operational performance.
At Takeda, as Vice President and Global Head of Device, Digital Innovation & Product Strategy, Ravi led cross functional device, digital health, and drug delivery platform development, building an integrated ecosystem of connected therapeutics and advanced delivery technologies. He also stood up an internal medtech “startup” within a $7.5B business unit, demonstrating his ability to architect and scale transformative device strategies in complex global settings.
As CEO of Transasia Biomedicals, India’s largest IVD company, he successfully led a 1,000 employee organization with full P&L responsibility (~$120M), driving organizational strategy, commercial excellence, manufacturing, R&D, and global expansion. His proven ability to run an end to end healthcare technology enterprise demonstrates his ability to lead a medical device company with both operational rigor and visionary direction.
Ravi’s Asia Pacific leadership at Medtronic included steering a $120M diabetes therapy portfolio across Japan, Korea, ANZ, and Southeast Asia. He led multiple new product launches, advanced regional market development, built patient centric business models, and achieved record setting growth—with global CEO awards for transformative leadership and high performance team engagement.
Earlier at Baxter/Baxalta, he led Strategy, Innovation, and P&L for India and APAC markets, where he delivered 40%+ revenue growth, championed business model innovation for chronic care therapies, and developed new patient access models that generated multimillion dollar growth.
His global marketing leadership at GE Healthcare reinforced his expertise in emerging market innovation, multi generational product development, and disruptive technology platforms—launching new devices, leading reverse innovation programs, and growing business segments by several hundred percent across Asia, Europe, Africa, and Latin America.
A proven CEO, entrepreneur and global healthcare executive, Ravi brings the rare combination of Medtech innovation, commercial leadership, and business transformation expertise. global market fluency, and a track record of building winning teams and launching breakthrough products across mature and emerging markets. His passion for patient centric innovation—combined with his ability to convert strategy into disciplined execution—makes him an exceptional CEO for a medical device company shaping the future of health tech worldwide.

ROPHAI provides AI-guided robotic phlebotomy for vein access, transforming blood and plasma donation. Its AI-enabled robotic healthcare automation aims to make every blood draw safe, painless, and accurate by eliminating needle-stick failure. The technology removes fear, friction, and variability from vascular access, strengthening the global donation supply.